Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 HTLV-II endemicity among Guaymi Indians in Panama.

× No keyword cloud information.

20 in total

Review 1. Comparative biology of human T-cell lymphotropic virus type 1 (HTLV-1) and HTLV-2.

Authors: Gerold Feuer; Patrick L Green
Journal: Oncogene Date: 2005-09-05 Impact factor: 9.867

2. Sensitive and specific polymerase chain reaction assays for diagnosis of human T-cell lymphotropic virus type I (HTLV-I) and HTLV-II infections in HTLV-I/II-seropositive individuals.

Authors: W Heneine; R F Khabbaz; R B Lal; J E Kaplan
Journal: J Clin Microbiol Date: 1992-06 Impact factor: 5.948

3. Molecular evidence for infection by HTLV-2 among individuals with negative serological screening tests for HTLV antibodies.

Authors: R Ishak; A C R Vallinoto; V N Azevedo; A C P Vicente; W W Hall; M O G Ishak
Journal: Epidemiol Infect Date: 2006-09-07 Impact factor: 2.451

4. Spontaneous cell proliferation is associated with poor sensitivity to glucocorticoids in patients infected with HTLV.

Authors: R P Lopes; M Menna-Barreto; M E Bauer
Journal: Cell Prolif Date: 2007-02 Impact factor: 6.831

5. High frequencies of human T-lymphotropic virus type I (HTLV-I) infection and presence of HTLV-II proviral DNA in blood donors with anti-thyroid antibodies.

Authors: H Mine; H Kawai; K Yokoi; M Akaike; S Saito
Journal: J Mol Med (Berl) Date: 1996-08 Impact factor: 4.599

6. Complete nucleotide sequence of an Amerindian human T-cell lymphotropic virus type II (HTLV-II) isolate: identification of a variant HTLV-II subtype b from a Guaymi Indian.

Authors: D Pardi; W M Switzer; K G Hadlock; J E Kaplan; R B Lal; T M Folks
Journal: J Virol Date: 1993-08 Impact factor: 5.103

7. HTLV-II infection in the Western United States.

Authors: B Hjelle
Journal: West J Med Date: 1994-06

8. Synthetic peptide-based immunoassays for distinguishing between human T-cell lymphotropic virus type I and type II infections in seropositive individuals.

Authors: R B Lal; W Heneine; D L Rudolph; W B Present; D Hofhienz; T M Hartley; R F Khabbaz; J E Kaplan
Journal: J Clin Microbiol Date: 1991-10 Impact factor: 5.948

9. Evaluation of an immunoblot assay for serological confirmation and differentiation of human T-cell lymphotropic virus types I and II.

Authors: B D Roberts; S K Foung; J J Lipka; J E Kaplan; K G Hadlock; G R Reyes; L Chan; W Heneine; R F Khabbaz
Journal: J Clin Microbiol Date: 1993-02 Impact factor: 5.948

10. Prevalence of HTLV types I and II among drug users in King County, Washington.

Authors: H Thiede; N V Harris; J P McGough; B Roberts; R F Khabbaz; J E Kaplan
Journal: West J Med Date: 1994-06